Literature DB >> 33049795

Importance and Evidence of Extent of Resection in Glioblastoma.

Victoria Wykes1,2, Athanasios Zisakis2, Mihaela Irimia2, Ismail Ughratdar2, Vijay Sawlani3, Colin Watts1,2.   

Abstract

Maximal safe resection is an essential part of the multidisciplinary care of patients with glioblastoma. A growing body of data shows that gross total resection is an independent prognostic factor associated with improved clinical outcome. The relationship between extent of glioblastoma (GB) resection and clinical benefit depends critically on the balance between cytoreduction and avoiding neurologic morbidity. The definition of the extent of tumor resection, how this is best measured pre- and postoperatively, and its relation to volume of residual tumor is still discussed. We review the literature supporting extent of resection in GB, highlighting the importance of a standardized definition and measurement of extent of resection to allow greater collaboration in research projects and trials. Recent developments in neurosurgical techniques and technologies focused on maximizing extent of resection and safety are discussed. Thieme. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 33049795     DOI: 10.1055/s-0040-1701635

Source DB:  PubMed          Journal:  J Neurol Surg A Cent Eur Neurosurg        ISSN: 2193-6315            Impact factor:   1.268


  6 in total

1.  First Report of Tumor Treating Fields (TTFields) Therapy for Glioblastoma in Comorbidity with Multiple Sclerosis.

Authors:  Rebecca Kassubek; René Mathieu
Journal:  Brain Sci       Date:  2022-04-13

2.  Defining the impact of adjuvant treatment on the prognosis of patients with inoperable glioblastoma undergoing biopsy only: does the survival benefit outweigh the treatment effort?

Authors:  Ronja Löber-Handwerker; Katja Döring; Christoph Bock; Veit Rohde; Vesna Malinova
Journal:  Neurosurg Rev       Date:  2022-02-23       Impact factor: 2.800

3.  Evaluation of a Navigated 3D Ultrasound Integration for Brain Tumor Surgery: First Results of an Ongoing Prospective Study.

Authors:  Danilo Aleo; Ziad Elshaer; Andreas Pfnür; Patrick J Schuler; Marco Maria Fontanella; Christian Rainer Wirtz; Andrej Pala; Jan Coburger
Journal:  Curr Oncol       Date:  2022-09-15       Impact factor: 3.109

4.  Reconfiguration from emergency to urgent elective neurosurgery for glioblastoma patients improves length of stay, surgical adjunct use, and extent of resective surgery.

Authors:  Rosa Sun; Shivam Sharma; Helen Benghiat; Sara Meade; Paul Sanghera; Gregory Bramwell; Santhosh Nagaraju; Ute Pohl; Camilla Dawson; Vladimir Petrik; Ismail Ughratdar; Anwen White; Athanasios Zisakis; Satheesh Ramalingam; Vijay Sawlani; Colin Watts; Victoria Wykes
Journal:  Neurooncol Pract       Date:  2022-05-02

5.  Predicting the true extent of glioblastoma based on probabilistic tractography.

Authors:  David Kis; Laszlo Szivos; Mark Rekecki; Bayan Salam Shukir; Adrienn Mate; Katalin Hideghety; Pal Barzo
Journal:  Front Neurosci       Date:  2022-09-21       Impact factor: 5.152

6.  Does positive MGMT methylation outbalance the limitation of subtotal resection in glioblastoma IDH-wildtype patients?

Authors:  Müller Mareike; Staub-Bartelt Franziska; Ehrmann Julia; Hänggi Daniel; Sabel Michael; Felsberg Jörg; Rapp Marion
Journal:  J Neurooncol       Date:  2021-06-29       Impact factor: 4.130

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.